93 related articles for article (PubMed ID: 21697059)
21. [Cost-effectiveness analysis comparing methotrexate with PUVA therapy for moderate-severe psoriasis in the sanitary area of Badajoz].
de Argila D; Rodríguez-Nevado I; Chaves A
Actas Dermosifiliogr; 2007; 98(1):35-41. PubMed ID: 17374331
[TBL] [Abstract][Full Text] [Related]
22. Changes in expression levels of genes involved in fatty acid metabolism: upregulation of all three members of the PPAR family (alpha, gamma, delta) and the newly described adiponectin receptor 2, but not adiponectin receptor 1 during neonatal cardiac development of the rat.
Steinmetz M; Quentin T; Poppe A; Paul T; Jux C
Basic Res Cardiol; 2005 May; 100(3):263-9. PubMed ID: 15754086
[TBL] [Abstract][Full Text] [Related]
23. Randomized, double-blind, placebo-controlled evaluation of the efficacy of oral psoralen plus ultraviolet A for the treatment of plaque-type psoriasis using the Psoriasis Area Severity Index score (improvement of 75% or greater) at 12 weeks.
Sivanesan SP; Gattu S; Hong J; Chavez-Frazier A; Bandow GD; Malick F; Kricorian G; Koo J
J Am Acad Dermatol; 2009 Nov; 61(5):793-8. PubMed ID: 19766350
[TBL] [Abstract][Full Text] [Related]
24. Peroxisome proliferator-activated receptor β/δ (PPARβ/δ) is highly expressed in liposarcoma and promotes migration and proliferation.
Wagner KD; Benchetrit M; Bianchini L; Michiels JF; Wagner N
J Pathol; 2011 Aug; 224(4):575-88. PubMed ID: 21598253
[TBL] [Abstract][Full Text] [Related]
25. [Comparison of RePUVA and aromatic retinoid Ro 10-9359 with methotrexate in severe forms of psoriasis].
Mashkilleysson AL; Mashkilleysson NA
Hautarzt; 1983 May; 34(5):229-30. PubMed ID: 6862887
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the serum T cell population variations induced by PUVA therapy.
Kokelj F; Presani G
Acta Derm Venereol Suppl (Stockh); 1989; 146():208-10. PubMed ID: 2609872
[TBL] [Abstract][Full Text] [Related]
27. Emerging roles of peroxisome proliferator-activated receptor-beta/delta in inflammation.
Bishop-Bailey D; Bystrom J
Pharmacol Ther; 2009 Nov; 124(2):141-50. PubMed ID: 19615407
[TBL] [Abstract][Full Text] [Related]
28. [Treatment of pustulous and erythrodermic psoriasis with PUVA therapy and methotrexate].
Leković B; Dostanić I; Konstantinović K; Kneitner I
Hautarzt; 1982 May; 33(5):284-5. PubMed ID: 7096093
[TBL] [Abstract][Full Text] [Related]
29. Peroxisome proliferator-activated receptor beta/delta exerts a strong protection from ischemic acute renal failure.
Letavernier E; Perez J; Joye E; Bellocq A; Fouqueray B; Haymann JP; Heudes D; Wahli W; Desvergne B; Baud L
J Am Soc Nephrol; 2005 Aug; 16(8):2395-402. PubMed ID: 15944338
[TBL] [Abstract][Full Text] [Related]
30. The demonstration of changes in bulbar conjunctiva surface epithelium in the psoriatic patients treated with PUVA.
Söker S; Nergiz Y; Cakmak S; Bahçeci S; Aytekin S
Ann Ophthalmol (Skokie); 2008; 40(2):94-8. PubMed ID: 19013916
[TBL] [Abstract][Full Text] [Related]
31. Randomized, double-blind comparison of 1 mg/L versus 5 mg/L methoxsalen bath-PUVA therapy for chronic plaque-type psoriasis.
Vongthongsri R; Konschitzky R; Seeber A; Treitl C; Hönigsmann H; Tanew A
J Am Acad Dermatol; 2006 Oct; 55(4):627-31. PubMed ID: 17010742
[TBL] [Abstract][Full Text] [Related]
32. [Management of severe psoriasis: about 50 cases].
Daoud L; Dhaoui MR; Youssef S; Jaber K; Doss N
Tunis Med; 2007 Oct; 85(10):849-56. PubMed ID: 18236807
[TBL] [Abstract][Full Text] [Related]
33. Peroxisome proliferator-activated receptor beta/delta activation inhibits hypertrophy in neonatal rat cardiomyocytes.
Planavila A; Rodríguez-Calvo R; Jové M; Michalik L; Wahli W; Laguna JC; Vázquez-Carrera M
Cardiovasc Res; 2005 Mar; 65(4):832-41. PubMed ID: 15721863
[TBL] [Abstract][Full Text] [Related]
34. Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis.
Strober B; Teller C; Yamauchi P; Miller JL; Hooper M; Yang YC; Dann F
Br J Dermatol; 2008 Aug; 159(2):322-30. PubMed ID: 18503600
[TBL] [Abstract][Full Text] [Related]
35. [The Koebner phenomenon, a prognostic sign of PUVA therapy effectiveness in patients with psoriasis vulgaris--yes or no?].
Matović L; Poljacki M; Duran V; Stojanović S; Subotić M
Med Pregl; 1999; 52(11-12):437-40. PubMed ID: 10748764
[TBL] [Abstract][Full Text] [Related]
36. Comparison of turbo-PUVA and conventional American-style PUVA in the treatment of psoriatic patients.
Moneib HA; Salem SA; Younis RM
Photodermatol Photoimmunol Photomed; 2010 Aug; 26(4):205-10. PubMed ID: 20626823
[TBL] [Abstract][Full Text] [Related]
37. The effectiveness of PUVA treatment in severe psoriasis is significantly increased by additional UV 308-nm excimer laser sessions.
Trott J; Gerber W; Hammes S; Ockenfels HM
Eur J Dermatol; 2008; 18(1):55-60. PubMed ID: 18086590
[TBL] [Abstract][Full Text] [Related]
38. Anti-tumour necrosis factor-alpha therapy increases body weight in patients with chronic plaque psoriasis: a retrospective cohort study.
Gisondi P; Cotena C; Tessari G; Girolomoni G
J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):341-4. PubMed ID: 18005022
[TBL] [Abstract][Full Text] [Related]
39. The role of peroxisome proliferator-activated receptor-beta/delta in epidermal growth factor-induced HaCaT cell proliferation.
Liang P; Jiang B; Yang X; Xiao X; Huang X; Long J; Zhang P; Zhang M; Xiao M; Xie T; Huang X
Exp Cell Res; 2008 Oct; 314(17):3142-51. PubMed ID: 18625220
[TBL] [Abstract][Full Text] [Related]
40. A pilot study of pharmacokinetically guided dosing of oral methotrexate in the initial phase of psoriasis treatment.
Hroch M; Chladek J; Simkova M; Vaneckova J; Grim J; Martinkova J
J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):19-24. PubMed ID: 18031504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
